Monograph
A10BD10 - Metformin and Saxagliptin |
Propably not porphyrinogenic |
PNP |
Rationale
Combination of two substances classified as NP (metformin) and PNP (saxagliptin).
For more extensive monographs, please search the individual substances metformin (ATC A10BA02) and saxagliptin (ATC A10BH03) in this database.
Chemical description
Metformin is a biguanide antidiabetic. Saxagliptin is a dipeptidyl peptidase-4 inhibitor.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Komboglyze · Komboglyze 2.5 mg/1000 mg, filmomhulde tabletten · Komboglyze 2.5 mg/850 mg, filmomhulde tablettenBelgium
Komboglyze · Komboglyze 2.5 mg - 1 000 mg compr. pellic. · Komboglyze 2.5 mg - 850 mg compr. pellic.United Kingdom
Komboglyze · Komboglyze 2.5mg/1000mg tablets · Komboglyze 2.5mg/850mg tabletsDenmark
KomboglyzePoland
KomboglyzeLuxembourg
KomboglyzeIceland
KomboglyzeFinland
KomboglyzeLatvia
Komboglyze
© NAPOS 2024